Artemis Medicare Services Ltd: Why Is It Outperforming Nifty 500?

Artemis Medicare Services Ltd's latest quarterly results (Mar 2026) show

• PAT Growth YoY: +30.4% (stable)
• Revenue Growth YoY: +16.3%
• Operating Margin: 18.0% (expanding)

Artemis Medicare Services Ltd's profit is growing with an stable trend.

• PAT Growth YoY: +30.4% (latest quarter)
• PAT Growth QoQ: +36.4% (sequential)
• 3-Year PAT CAGR: +39.9%
• Trend: Stable — consistent growth pattern

Artemis Medicare Services Ltd's revenue growth trend is stable.

• Revenue Growth YoY: +16.3%
• Revenue Growth QoQ: +2.6% (sequential)
• 3-Year Revenue CAGR: +13.6%

Artemis Medicare Services Ltd's operating margin is expanding.

• Current OPM: 18.0%
• OPM Change YoY: +3.0% basis points
• OPM Change QoQ: +2.0% basis points

Artemis Medicare Services Ltd's long-term compounding rates

• 3-Year Profit CAGR: +39.9%
• 3-Year Revenue CAGR: +13.6%

Artemis Medicare Services Ltd's earnings growth is stable with mixed signals on a sequential basis.

• YoY Acceleration: +25.6% bps
• Sequential Acceleration: +63.1% bps

Artemis Medicare Services Ltd's trailing twelve month (TTM) performance

• TTM PAT: ₹103 Cr
• TTM PAT Growth: +24.1% YoY
• TTM Revenue: ₹1,000 Cr
• TTM Revenue Growth: +15.5% YoY
• TTM Operating Margin: 17.0%

Artemis Medicare Services Ltd appears significantly overvalued based on our fair value analysis.

• Valuation Signal: Significantly Overvalued
• Current PE: 39.0x
• Price-to-Book: 4.4x

Artemis Medicare Services Ltd's current PE ratio is 39.0x.

• Current PE: 39.0x
• Market Cap: 4.1K Cr
• Dividend Yield: 0.17%

Artemis Medicare Services Ltd's current PE is 39.0x.

• Current PE: 39.0x
• Valuation Assessment: Significantly Overvalued

Artemis Medicare Services Ltd's price-to-book ratio is 4.4x.

• Price-to-Book (P/B): 4.4x
• Book Value per Share: ₹59
• Current Price: ₹261

Artemis Medicare Services Ltd is rated Average with a fundamental score of 55.3/100. This score is calculated from objective financial metrics

• Revenue Growth YoY: +16.3% (10% weight)
• PAT Growth YoY: +30.4% (10% weight)
• PAT Growth QoQ: +36.4% (10% weight)
• Margins expanding (10% weight)

Artemis Medicare Services Ltd has a debt-to-equity ratio of N/A.

• Total Debt: ₹262 Cr

Artemis Medicare Services Ltd's return ratios over recent years

• FY2024: ROCE 14.0%
• FY2025: ROCE 15.0%
• FY2026: ROCE 15.0%

Artemis Medicare Services Ltd's operating cash flow is positive (FY2026).

• Cash from Operations (CFO): ₹132 Cr
• Free Cash Flow (FCF): ₹42 Cr
• CFO/PAT Ratio: 127% (strong cash conversion)

Artemis Medicare Services Ltd's current dividend yield is 0.17%.

• Dividend Yield: 0.17%
• Current Price: ₹261

Artemis Medicare Services Ltd's shareholding pattern (Mar 2026)

• Promoters: 58.4%
• FII (Foreign): 12.2%
• DII (Domestic): 2.9%
• Public: 20.4%

Artemis Medicare Services Ltd's promoter holding has increased recently.

• Current Promoter Holding: 58.4% (Mar 2026)
• Previous Quarter: 58.4% (Dec 2025)
• Change: +0.01% (increasing — positive signal)

Artemis Medicare Services Ltd has been outperforming Nifty 500 for 6 consecutive weeks, indicating building momentum.

Artemis Medicare Services Ltd is an established outperformer with 6 weeks of consecutive Nifty 500 outperformance.

Based on quantitative research signals, here is why Artemis Medicare Services Ltd may be worth studying

• Earnings growing at +30.4% YoY
• Operating margins are expanding — OPM at 18.0%
• Cash flow is positive — CFO ₹132 Cr

Artemis Medicare Services Ltd investment thesis summary:

Artemis Medicare Services Ltd's forward outlook based on current data signals

• Earnings Trend: stable
• Revenue Trend: stable
• Margin Trend: expanding
• Valuation: Significantly Overvalued